메인 메뉴
ABOUT US
Overview
History
Leadership
Contact Us
R&D
R&D Strategy
Therapeutic Areas
Scientific References
PIPELINE
Pipeline
Pipeline details
INVESTORS & MEDIA
NEWS & EVENT
CAREERS
검색어 입력 필수
INVESTORS & MEDIA
INVESTORS & MEDIA
ABOUT US
R&D
PIPELINE
INVESTORS & MEDIA
CAREERS
NEWS & EVENT
NEWS & EVENT
Home
INVESTORS & MEDIA
NEWS & EVENT
NEWS & EVENT
Total 7 - 1 page
No
Subject
Date
Hit
7
iLeadBMS Presents Preclinical Data on Novel Drug Candidate for Heart Failure at AFDD
2024.11.21
48
익명
48
2024.11.21
6
iLeadBMS’ Cyclin-K Molecular Glue Receives ODD from FDA for Gastric Cancer
2024.10.07
384
익명
384
2024.10.07
5
iLeadBMS Announces Positive Liver Fibrosis Results of IL1512 (CXCR7 Agonist) at the EASL 2024
2024.07.10
565
익명
565
2024.07.10
4
iLeadBMS Announces Positive Preclinical Results of IL1512 (CXCR7 Agonist) at the ATS 2024
2024.05.21
457
익명
457
2024.05.21
3
iLeadBMS Announces Results of TPD Molecular Glue Research of IL2106 (CDK12 Molecular Glue and Cyclin-K degrader) at ESMO TAT 2024
2024.02.27
754
익명
754
2024.02.27
2
Ildong Pharmaceutical Group’s ‘iLeadBMS’ Presents Non-Clinical Results of its Novel NASH Drug Candidate at the AASLD
2022.11.09
410
익명
410
2022.11.09
1
Ildong Pharmaceutical Invests KRW 13,000,000,000 in iLeadBMS to Strengthen the Ecosystem of Novel Drug R&D
2021.07.15
320
익명
320
2021.07.15
×
NOTICE 검색
검색대상
제목
내용
제목+내용
회원아이디
회원아이디(코)
글쓴이
글쓴이(코)
검색어
필수
검색
1
페이지
×
전체 게시판 검색
검색어 입력 필수
검색
×
사용후기 작성하기
×
상품문의 작성하기
×
쿠폰 내역
×
투표 결과 보기